(Q40122841)

17 September 2017

Analysis of non-relapse mortality and causes of death over 15 years following allogeneic hematopoietic stem cell transplantation (English)

1 reference

17 September 2017

Y Tanaka

1

1 reference

17 September 2017

S Kurosawa

2

1 reference

17 September 2017

K Tajima

3

1 reference

17 September 2017

T Tanaka

4

1 reference

17 September 2017

R Ito

5

1 reference

17 September 2017

Y Inoue

6

1 reference

17 September 2017

K Okinaka

7

1 reference

17 September 2017

Y Inamoto

8

1 reference

17 September 2017

S Fuji

9

1 reference

17 September 2017

S-W Kim

10

1 reference

17 September 2017

R Tanosaki

11

1 reference

17 September 2017

T Yamashita

12

1 reference

17 September 2017

T Fukuda

13

1 reference

17 September 2017

language of work or name

English

0 references

publication date

11 January 2016

1 reference

Bone Marrow Transplantation

17 September 2017

1 reference

17 September 2017

51

1 reference

17 September 2017

4

1 reference

17 September 2017

553-559

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2015.330

17 September 2017

0 references

cites work

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Reduced mortality after allogeneic hematopoietic-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Changes in incidence and causes of non-relapse mortality after allogeneic hematopoietic cell transplantation in patients with acute leukemia/myelodysplastic syndrome: an analysis of the Japan Transplant Outcome Registry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Recent decrease in non-relapse mortality due to GVHD and infection after allogeneic hematopoietic cell transplantation in non-remission acute leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Defining the intensity of conditioning regimens: working definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Investigation of the freely available easy-to-use software 'EZR' for medical statistics

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Blood stream infection (BSI) and acute GVHD after hematopoietic SCT (HSCT) are associated

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Diabetes, hyperglycemia, and infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Intensive glucose control after allogeneic hematopoietic stem cell transplantation: a retrospective matched-cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Improved survival with ursodeoxycholic acid prophylaxis in allogeneic stem cell transplantation: long-term follow-up of a randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Clofarabine and busulfan conditioning facilitates engraftment and provides significant antitumor activity in nonremission hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Azacitidine for treatment of imminent relapse in MDS or AML patients after allogeneic HSCT: results of the RELAZA trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Long-term follow-up of allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: impact of tyrosine kinase inhibitors on treatment outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Improved Survival after Allogeneic Hematopoietic Stem Cell Transplantation in Recent Years. A Single-Center Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2015.330

Tacrolimus instead of cyclosporine used for prophylaxis against graft-versus-host disease improves outcome after hematopoietic stem cell transplantation from unrelated donors, but not from HLA-identical sibling donors: a nationwide survey conducted

21 January 2018

1 reference

12 December 2020

A risk score for mortality after allogeneic hematopoietic cell transplantation

1 reference

12 December 2020

Continuous reduced nonrelapse mortality after allogeneic hematopoietic stem cell transplantation: a single-institution's three decade experience

1 reference

12 December 2020

1994 Consensus Conference on Acute GVHD Grading

1 reference

12 December 2020

Increased risk of infection in marrow transplant patients receiving methylprednisolone for graft-versus-host disease prevention

1 reference

12 December 2020

Prognostic impact of minimal residual disease analysis by flow cytometry in patients with acute myeloid leukemia before and after allogeneic hemopoietic stem cell transplantation

1 reference

12 December 2020

Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

1 reference

12 December 2020

Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2015.330

1 reference

Dimensions Publication ID

17 September 2017

1047807155

0 references

Fatcat ID

release_xk4gdmbkvfgkzneqzxtghzedk4

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/xk4gdmbkvfgkzneqzxtghzedk4

24 November 2022

mapped directly with Wikidata item

1 reference